BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18164769)

  • 1. Do statins decrease cardiovascular disease at the expense of increasing cancer?
    Goldstein MR; Mascitelli L
    Int J Cardiol; 2009 Apr; 133(2):254-5. PubMed ID: 18164769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins, low-density lipoprotein cholesterol, and risk of cancer.
    Alsheikh-Ali AA; Trikalinos TA; Kent DM; Karas RH
    J Am Coll Cardiol; 2008 Sep; 52(14):1141-7. PubMed ID: 18804740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects and cholesterol-lowering therapy.
    Shaw SM; Fildes JE; Yonan N; Williams SG
    Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The double-edged sword of statin immunomodulation.
    Goldstein MR; Mascitelli L; Pezzetta F
    Int J Cardiol; 2009 Jun; 135(1):128-30. PubMed ID: 18485499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and cancer: a potential link?
    Thompson JS; Sood A; Arora R
    Am J Ther; 2010; 17(4):e100-4. PubMed ID: 19451806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intensive statin therapy in the elderly.
    Maroo BP; Lavie CJ; Milani RV
    Am J Geriatr Cardiol; 2008; 17(2):92-100. PubMed ID: 18326948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
    Hausenloy DJ; Yellon DM
    Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-altering drugs: decreasing cardiovascular disease at the expense of increasing cancer?
    Goldstein MR; Murao K; Imachi H; Ishida T; Wong NC
    Cancer Res; 2004 Sep; 64(18):6831; author reply 6831-2. PubMed ID: 15375004
    [No Abstract]   [Full Text] [Related]  

  • 16. Monotherapy vs combination therapy for dyslipidemia in the elderly.
    Shepherd J
    Am J Geriatr Cardiol; 2008; 17(2):108-13. PubMed ID: 18326949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy and statins.
    Prescrire Int; 2007 Dec; 16(92):247-8. PubMed ID: 18092417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulatory properties of statins and cancer risk].
    Mascitelli L; Goldstein MR; Pezzetta F
    Recenti Prog Med; 2009 Jan; 100(1):33-9. PubMed ID: 19445281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid management in the geriatric patient.
    Nair AP; Darrow B
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.